Breaking the Cycle: Telehealth Treatment for People in Custody is Key to Recidivism Disruption
It’s no secret that opioids have reshaped the landscape of our nation: Our healthcare system, our policymakers, and our criminal ...
It’s no secret that opioids have reshaped the landscape of our nation: Our healthcare system, our policymakers, and our criminal ...
With around 20,000 people dying of covid in the United States since the start of October, and tens of thousands ...
As the United States experiences demographic shifts, accelerated aging is becoming a notable trend with profound implications for various sectors, ...
Artificial Intelligence has the potential to greatly improve clinical care and support the transition to value-based care, but also comes ...
The Centers for Medicare and Medicaid Services finalized the CMS Interoperability and Prior Authorization Rule on Wednesday. CMS said the ...
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Loewen Cavill, co-founder and CEO of Amira, never expected to work in the menopause space. But then her aunt was ...
The legal status of marijuana in the United States is comparable to the Korean War: The conflict ceased long ago, ...
Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urology portfolio. The company is ...
Copyright © 2024 DerInformant.
DerInformant.com is not responsible for the content of external sites.
DerInformant.com is a proud member of BXL MEDIA
Copyright © 2024 DerInformant.
DerInformant.com is not responsible for the content of external sites.
DerInformant.com is a proud member of BXL MEDIA
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.